Pharmac's set-up risks higher health costs: medicines research

Pharmac's set-up risks higher health costs: medicines research
New Zealand's spending on modern pharmaceuticals sits far below comparable OECD countries. (Image: NZIER for Medicines NZ)
Pattrick Smellie
The Government's drug-buying agency, Pharmac, is being criticised for its inability to drive hard bargains with Big Pharma, which may be restricting New Zealanders’ access to modern medicines and driving demand for high-cost hospital care.Those are primary conclusions of research for Medicines New Zealand by the NZ Institute of Economic Research (NZIER), examining why NZ’s national pharmaceutical spend is among the lowest in the rich countries club, the Organisation for Economic Cooperation and Development (OECD).The study concl...

More Economy

No respite for the NZ dollar
Economy

No respite for the NZ dollar

Easing trade tensions isn’t helping the NZ dollar. 

Rebecca Howard 22 Oct 2025
RBNZ and the curious case of prudential stacks
Opinion

Andy Macdonald: RBNZ and the curious case of prudential stacks

The end result of the RBNZ’s capital review will be both revealing and fascinating.

Andy Macdonald 21 Oct 2025
Economists expect a 25bps cut in Nov, inflation as expected
Economy

Economists expect a 25bps cut in Nov, inflation as expected

Annual inflation was 3%, within the 1% to 3% band. 

Rebecca Howard 20 Oct 2025